Dr. Brandon Bright DAOM provides an honest physician review of BPC-157 safety — addressing kidney concerns, blood pressure effects, anxiety reports, and why physician supervision matters.
Read article →
By Dr. Brandon Bright, DAOM, LAc · Doctor of Acupuncture & Oriental Medicine · Functional Medicine University-certified · Tustin, CA · Last reviewed: June 19, 2026 GLP-1 medications…
Read article →
By Dr. Brandon Bright, DAOM, LAc · Doctor of Acupuncture & Oriental Medicine · Functional Medicine University-certified · Tustin, CA · Last reviewed: June 9, 2026 Eli Lilly…
Read article →
By Dr. Brandon Bright, DAOM, LAc · Doctor of Acupuncture & Oriental Medicine · Functional Medicine University-certified · Clinical Hypnotherapist · Tustin, CA · Last reviewed: June 8,…
Read article →
Reviewed by Dr. Brandon Bright, DAOM, LAcDoctor of Acupuncture and Oriental Medicine, functional medicine clinician, and founder of Holistic Dr. Bright in Tustin, California. What is Applied Kinesiology…
Read article →
The short answer BPC-157 is a synthetic peptide derived from a protein found in human gastric juice. It’s studied primarily for tissue repair, gut lining integrity, and connective-tissue…
Read article →
After the April 23, 2026 Cat-1 reclassification, the only legal pathway to BPC-157 is physician prescription + state-licensed 503A compounding pharmacy. Research-chemical websites and 503B bulk-compounded supply are…
Read article →
The FDA proposal to add GLP-1 to 503B outsourcing-facility regulations reshapes the peptide-therapy landscape. GLP-1 and peptides both live in the compounding-pharmacy space. They compete for prescriber attention…
Read article →
The FDA proposed (April 30, 2026) restricting bulk-compounded GLP-1 medications (semaglutide, tirzepatide) from 503B outsourcing facilities. Patients on compounded GLP-1 through telehealth platforms face structural supply uncertainty. Brand-name…
Read article →
Cash-pay functional medicine clinics are rare. FSA and HSA coverage for acupuncture functional medicine labs and peptide therapy through a Letter of Medical Necessity is rarer still and…
Read article →